A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses

(2012) Chen-Yi Chiang et al.   PLoS Neglected Tropical Diseases

A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses

(2011) Chen-Yi Chiang et al.   PLoS One

CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination

(2010) L. E. Yauch et al.   JOURNAL OF IMMUNOLOGY

Inhibition of the Type I Interferon Response in Human Dendritic Cells by Dengue Virus Infection Requires a Catalytically Active NS2B3 Complex

(2010) J. R. Rodriguez-Madoz et al.   JOURNAL OF VIROLOGY

Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2

(2010) S. Sukupolvi-Petty et al.   JOURNAL OF VIROLOGY

Dengue: a continuing global threat

(2010) Maria G. Guzman et al.   NATURE REVIEWS MICROBIOLOGY

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

(2010) David E. Clements et al.   VACCINE

NS5 of Dengue Virus Mediates STAT2 Binding and Degradation

(2009) J. Ashour et al.   JOURNAL OF VIROLOGY

Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation

(2009) Hsien-Jen Cheng et al.   MOLECULAR IMMUNOLOGY

A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design

(2009) Hsin-Wei Chen et al.   VACCINE

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

(2009) W.M.P.B. Wahala et al.   VIROLOGY

Global Spread and Persistence of Dengue

(2008) Jennifer L. Kyle et al.   Annual Review of Microbiology

Dose-Dependent Protection against or Exacerbation of Disease by a Polylactide Glycolide Microparticle-Adsorbed, Alphavirus-Based Measles Virus DNA Vaccine in Rhesus Macaques

(2008) C.-H. Pan et al.   Clinical and Vaccine Immunology

A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus

(2008) K. Raviprakash et al.   JOURNAL OF VIROLOGY

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

(2008) C.-Y. Lai et al.   JOURNAL OF VIROLOGY

A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity

(2008) Chih-Hsiang Leng et al.   MICROBES AND INFECTION

The Mannose Receptor Mediates Dengue Virus Infection of Macrophages

(2008) Joanna L. Miller et al.   PLoS Pathogens